Ушбу ишга иқтибос қилган ишлар

6 та иш

Иш: [6]-Shogaol/β-CDs inclusion complex: preparation, characterisation, <i>in vivo</i> pharmacokinetics, and <i>in situ</i> intestinal perfusion study

1. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A

   Zhongan Zhu, Jing Liu, Yuhang Yang +6

   МақолаPharmacological Effects of Natural CompoundsJournal of Microencapsulation20213 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000190

2. Enhanced oral bioavailability and anti‐hyperuricemic activity of liquiritin via a self‐nanoemulsifying drug delivery system

   Chunmei Wei, Qilong Wang, Wen Weng +5

   МақолаGout, Hyperuricemia, Uric AcidJournal of the Science of Food and Agriculture20213 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000311

3. Isoliquiritigenin Containing PH Sensitive Micelles for Enhanced Anti-Colitis Activity

   Feng Shi, Mengzhe Du, Qin Wang +8

   МақолаPharmacological Effects of Natural CompoundsJournal of Pharmaceutical Sciences20233 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.000717

4. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation

   Qilong Wang, Kangyi Zhang, Wen Weng +11

   МақолаPharmacological Effects of Natural CompoundsJournal of Pharmaceutical Sciences20221 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000271

5. Enhancement of oral bioavailability and hypoglycemic activity of liquiritin-loaded precursor liposome

   Qilong Wang, Chunmei Wei, Wen Weng +6

   МақолаPharmacological Effects of Natural CompoundsInternational Journal of Pharmaceutics20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000157

6. Preparation of PEG-modified isoquercitrin liposomes and anti-chronic kidney disease research

   Qinyang Hua, Qilong Wang, Xue Wang +12

   МақолаNanoparticle-Based Drug DeliveryJournal of Liposome Research20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.001040